Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for squamous cell carcinoma of the oral tongue has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include procedural interventions and other interventions. Pipeline includes 1 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
122 publications have been identified in PubMed for squamous cell carcinoma of the oral tongue. Research spans Clinical Trial Publication (31%), Diagnostic / Biomarker (22%), and Basic Science / Preclinical (19%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 38 |
Data assembled from 4 of 12 sources · Last updated Sep 21, 2026, 2:33 AM UTC
European rare disease database
31%
Testing and diagnosis research | 27 | 22% |
Laboratory research | 23 | 19% |
Disease patterns and progression | 19 | 16% |
New treatment approaches | 6 | 5% |
Patient case studies | 5 | 4% |
Research summaries | 3 | 2% |
Other research | 1 | 1% |
Chakrabarty N (2026). [PMID: 42057830](https://pubmed.ncbi.nlm.nih.gov/42057830/). *Front Oncol*. [Diagnostic / Biomarker]
Togni L (2026). [PMID: 41682645](https://pubmed.ncbi.nlm.nih.gov/41682645/). *Journal of clinical medicine*. [Clinical Trial Publication]
Liu S (2026). [PMID: 42048980](https://pubmed.ncbi.nlm.nih.gov/42048980/). *J Craniomaxillofac Surg*. [Diagnostic / Biomarker]
Lu HZ (2026). [PMID: 40839952](https://pubmed.ncbi.nlm.nih.gov/40839952/). *Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy*. [Gene Therapy / Novel Therapeutics]
Gumedag C (2026). [PMID: 41779475](https://pubmed.ncbi.nlm.nih.gov/41779475/). *Journal of applied oral science : revista FOB*. [Gene Therapy / Novel Therapeutics]
Lee J (2026). [PMID: 40874429](https://pubmed.ncbi.nlm.nih.gov/40874429/). *Head & neck*. [Review / Meta-Analysis]
Ren J (2026). [PMID: 41486170](https://pubmed.ncbi.nlm.nih.gov/41486170/). *Cancer imaging : the official publication of the International Cancer Imaging Society*. [Clinical Trial Publication]
Fekrazad S (2026). [PMID: 41612054](https://pubmed.ncbi.nlm.nih.gov/41612054/). *Discover oncology*. [Clinical Trial Publication]
Gang Q (2026). [PMID: 41684966](https://pubmed.ncbi.nlm.nih.gov/41684966/). *Therapeutic advances in medical oncology*. [Diagnostic / Biomarker]
Almangush A (2026). [PMID: 41825146](https://pubmed.ncbi.nlm.nih.gov/41825146/). *Oral oncology*. [Clinical Trial Publication]
AI-curated news mentioning squamous cell carcinoma of the oral tongue
Updated Sep 1, 2026
A case report highlights a rare instance of cutaneous metastasis from oral squamous cell carcinoma, suggesting the potential role of GALR2 as a biomarker. This discovery could inform future research and diagnostic approaches in oncology.
A case report highlights an unusual cardiac metastasis from oral squamous cell carcinoma, contributing to the understanding of this rare phenomenon. The findings may inform future research and clinical approaches to similar cases.
A case report highlights the synchronous occurrence of oral squamous cell carcinoma and aggressive papillary thyroid microcarcinoma, along with regional metastasis in cervical lymph nodes. This finding may provide insights into the complex interactions between these cancers.